McKay, R. R., Atherton, P. J., Ballman, K. V., Jacene, H., Chen, R. C., Choudhury, A. D., Lang, J. M., Cole, S., Baghdadi, T. A., Kwok, Y., Tan, A., Berg, S. A., Beltran, H., Morris, M. J., McGregor, B. A., Zhang, T., Galsky, M. D., Rosenberg, J. E., George, D. J., Choueiri, T. K. (2026). A phase 2 randomized trial of radium-223 dichloride and cabozantinib in patients (pts) with renal cell carcinoma (RCC) with bone metastases (BM): RADICAL (Alliance A031801).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4500